Related Experiment Video

Updated: Jun 5, 2026

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling
07:51

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling

Published on: March 20, 2026

CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease

Federica Borghese1, Felix I L Clanchy

  • 1Sapienza University of Rome, Department of Clinical Medicine, Clinical Immunology Unit, Umberto I Policlinico di Roma, 155 Viale del Policlinico, Rome, IT 00161.

Expert Opinion on Therapeutic Targets
|January 7, 2011
PubMed

Insights

CD74, the invariant chain, is crucial for immune responses and disease. Its interactions with MIF and cathepsins offer promising therapeutic targets for various conditions.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • CD74, the invariant chain, plays a vital role in immune system processes like antigen presentation and inflammatory signaling.
  • Despite being known for over 30 years, new functions and interactions of CD74 continue to be discovered.
  • CD74's involvement in immunological processes and disease states highlights its potential as a therapeutic target.

Purpose of the Study:

  • To review the relationship between CD74 structure and function.
  • To examine CD74's role in various cell lineages and its interactions with cathepsins and macrophage migratory inhibitory factor (MIF).
  • To outline CD74 signaling in inflammation and cancer, and its therapeutic applications.

Main Methods:

  • Literature review focusing on CD74 structure-function relationships.
  • Analysis of CD74 interactions with cathepsins and MIF in inflammatory contexts.
  • Examination of CD74 signaling pathways in inflammatory and carcinogenic processes.

Main Results:

  • CD74 exhibits complex interactions with MIF and cathepsins, influencing immune responses.
  • CD74 signaling is implicated in inflammatory and carcinogenic pathways.
  • CD74 serves as a potential therapeutic target in cancer and as a vaccine component.

Conclusions:

  • CD74 has diverse roles within cells and the immune system.
  • The interplay between CD74, MIF, and cathepsins is a key area of focus.
  • Modulating CD74 function holds promise for disease amelioration.
Abstract

More Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...